Chemical pharmacotherapy options for managing adult acne

References

• Goulden V, Clark SM, Cunliffe WJ. Post-adolescent acne: a review of clinical features. Br J Dermatol. 1997;136(1):66–70.
   PubMed Web of Science ®Google Scholar
• Toyoda M, Morohashi M. Pathogenesis of acne. Med Electron Microsc. 2001;34(1):29–40. DOI:10.1007/s0079510340029.
   PubMedGoogle Scholar
• Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatology Venereol. 2001;15(6):541–545. DOI:10.1046/j.1468-3083.2001.00357.x
   PubMed Web of Science ®Google Scholar
• Addor FAS, Schalka S. Acne in adult women: epidemiological, diagnostic and therapeutic aspects. An Bras Dermatol. 2010;85(6):789–795.
   PubMed Web of Science ®Google Scholar
• Williams C, Layton AM. Persistent acne in women : implications for the patient and for therapy.: zasoby Biblioteki Głównej GUMed. Am J Clin Dermatol. 2006;7(5):281–290. Available from: http://eds.b.ebscohost.com/eds/pdfviewer/pdfviewer?sid=0054546a-d34c-4981-bf1e-9071dbbdd403@sessionmgr115&vid=8&hid=122
   PubMed Web of Science ®Google Scholar
• Passarini B, Infusino SD, Kasapi E. Chloracne: still cause for concern. Dermatology (Basel, Switzerland). 2010;221(1):63–70. DOI:10.1159/000290694
   PubMed Web of Science ®Google Scholar
• Tanghetti EA, Kawata AK, Daniels SR, et al. Understanding the burden of adult female acne. J Clin Aesthet Dermatol. 2014 [cited 2016 Dec 21];7(2):22–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24578779
   PubMedGoogle Scholar
• Tahir CM. Pathogenesis of acne vulgaris: simplified. J Pakistan Assoc Dermatologists. 2010;20:93–97.
   Google Scholar
• Pochi PE. The pathogenesis and treatment of acne. Annu Rev Med. 1990;41:187–198. DOI:10.1146/annurev.me.41.020190.001155
   PubMed Web of Science ®Google Scholar
• Brown SK, Shalita AR. Acne vulgaris. Lancet (London, England). 1998;351(9119):1871–1876. DOI:10.1016/S0140-6736(98)01046-0
   PubMed Web of Science ®Google Scholar
• Khunger N, Kumar C. A clinico-epidemiological study of adult acne: is it different from adolescent acne? Indian J Dermatol Venereol Leprol. 2012;78(3):335–341. DOI:10.4103/0378-6323.95450
   PubMed Web of Science ®Google Scholar
• Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J Am Acad Dermatol. 1999 [cited 2016 Aug 10];41(4):577–580. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10495379
   PubMed Web of Science ®Google Scholar
• Cibula D, Hill M, Vohradnikova O, et al. The role of androgens in determining acne severity in adult women. Br J Dermatol. 2000;143(2):399–404. DOI:10.1046/j.1365-2133.2000.03669.x
   PubMed Web of Science ®Google Scholar
• Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945–973e33. DOI:10.1016/j.jaad.2015.12.037
   PubMed Web of Science ®Google Scholar
• Goulden V, Clark SM, Cunliffe WJ. Post-adolescent acne: a review of clinical features. Br J Dermatol. 1997 [cited 2016 Aug 10];136(1):66–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9039297
   PubMed Web of Science ®Google Scholar
• Dreno B, Thiboutot D, Layton AM, et al. Large-scale international study enhances understanding of an emerging acne population: adult females. J Eur Acad Dermatology Venereol. 2015;29(6):1096–1106. DOI:10.1111/jdv.12757
   PubMed Web of Science ®Google Scholar
• Capitanio B, Sinagra JL, Bordignon V, et al. Underestimated clinical features of postadolescent acne. J Am Acad Dermatol. 2010;63(5):782–788. DOI:10.1016/j.jaad.2009.11.021
   PubMed Web of Science ®Google Scholar
• Rivera R, Guerra A. Management of acne in women over 25 years of age. Actas Dermo-Sifiliográficas (English Ed). 2009;100(1):33–37. DOI:10.1016/S1578-2190(09)70007-1
   PubMedGoogle Scholar
• Berson D, Alexis A. Adapalene 0.3% for the treatment of acne in women. J Clin Aesthet Dermatol. 2013;6(10):32–35.
   PubMedGoogle Scholar
• Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: adouble-blind, randomized, vehicle-controlled study. Cutis. 2006;77(1):45–50.
   PubMed Web of Science ®Google Scholar
• Nau H. Embryotoxicity and teratogenicity of topical retinoic acid. Skin Pharmacol Physiol. 2009;6(1):35–44. DOI:10.1159/000211162
   Google Scholar
• Del Rosso JQ, Harper JC, Graber EM, et al. Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 2: topical therapies. Cutis. 2015 [cited 2016 Aug 10];96(5):321–325. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26682555
   PubMed Web of Science ®Google Scholar
• Thielitz A, Lux A, Wiede A, et al. A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne. J Eur Acad Dermatology Venereol. 2015;29(4):789–796. DOI:10.1111/jdv.12823
   PubMed Web of Science ®Google Scholar
• Del Rosso JQ, Harper JC, Graber EM, et al. Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 3: oral therapies. Cutis. 2015 [cited 2016 Aug 10];96(6):376–382. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26761932
   PubMed Web of Science ®Google Scholar
• Dréno B, Layton A, Zouboulis CC, et al. Adult female acne: a new paradigm. J Eur Acad Dermatology Venereol. 2013;27(9):1063–1070. DOI:10.1111/jdv.12061
   PubMed Web of Science ®Google Scholar
• Zeichner JA. The efficacy and tolerability of a fixed combination clindamycin (1.2%) and benzoyl peroxide (3.75%) aqueous gel in adult female patients with facial acne vulgaris. J Clin Aesthet Dermatol. 2015;8(4):21–25.
   PubMedGoogle Scholar
• Tanghetti E, Harper JC, Oefelein MG. The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: gender as a clinically relevant outcome variable. J Drugs Dermatol. 2012 [cited 2016 Dec 21];11(12):1417–1421. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23377510.
   PubMed Web of Science ®Google Scholar
• Thiboutot DM, Kircik L, McMichael A, et al. Efficacy, safety, and dermal tolerability of dapsone gel, 7.5% in patients with moderate acne vulgaris: a pooled analysis of two phase 3 trials. J Clin Aesthet Dermatol. 2016 [cited 2016 Dec 21];9(10):18–27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27847545
   Google Scholar
• Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol. 2001;45(5):150–157. DOI:10.1067/mjd.2001.113717
   PubMed Web of Science ®Google Scholar
• Seukeran DC, Cunliffe WJ. Acne vulgaris in the elderly: the response to low-dose isotretinoin. Br J Dermatol. 1998 [cited 2016 Aug 10];139(1):99–101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9764156
   PubMed Web of Science ®Google Scholar
• Rademaker M, Wishart JM. Birchall NM. Isotretinoin 5 mg daily for low-grade adult acne vulgaris - a placebo-controlled, randomized double-blind study. J Eur Acad Dermatol Venereol. 2013;1–8. DOI:10.1111/jdv.12170
   Web of Science ®Google Scholar
• Arowojolu AO, Gallo MF, Lopez LM, et al. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012;7:CD004425. DOI:10.1002/14651858.CD004425.pub6
   Web of Science ®Google Scholar
• Shaw JC. Acne: effect of hormones on pathogenesis and management. Am J Clin Dermatol. 2002;3(8):571–578. DOI:10.2165/00128071-200203080-00007
   PubMedGoogle Scholar
• Rabe T, Kowald A, Ortmann J, et al. Inhibition of skin 5α-reductase by oral contraceptive progestins in vitro. Gynecol Endocrinol. 2000 [cited 2016 Aug 30];14(4):223–230. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11075290
   PubMed Web of Science ®Google Scholar
• Ebede TL, Arch EL, Berson D. Hormonal treatment of acne in women. J Clin Aesthet Dermatol. 2009;2(12):16–22. cited 2016 Sep 3 Available from: http://www.ncbi.nlm.nih.gov/pubmed/20725580.
   PubMedGoogle Scholar
• Keri J, Berson D, Thiboutot D. Hormonal treatment of acne in women. In: Shalita A, Del Rosso J, Webster G, editors. Acne vulgaris. London: Informa Healthcare; 2011. p. 146–155.
   Google Scholar
• Palli MBA, Reyes-Habito CM, Lima XT, et al. A single-center, randomized double-blind, parallel-group study to examine the safety and efficacy of 3mg drospirenone/0.02 mg ethinyl estradiol compared with placebo in the treatment of moderate truncal acne vulgaris. J Drugs Dermatol. 2013 [cited 2016 Aug 30];12(6):633–637. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23839178
   PubMed Web of Science ®Google Scholar
• Koltun W, Lucky AW, Thiboutot D, et al. Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial. Contraception. 2008;77(4):249–256. DOI:10.1016/j.contraception.2007.11.003
   PubMed Web of Science ®Google Scholar
• Kerscher M, Reuther T, Bayrhammer J, et al. Effects of an oral contraceptive containing chlormadinone and ethinylestradiol on acne-prone skin of women of different age groups: an open-label, single-centre, phase IV study. Clin Drug Investig. 2008;28(11):703–711. DOI:10.2165/00044011-200828110-00004
   PubMed Web of Science ®Google Scholar
• van Vloten WA, van Haselen CW, van Zuuren EJ, et al. The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. Cutis. 2002 [cited 2016 Dec 22];69(4 Suppl):2–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12096825
   PubMedGoogle Scholar
• Redmond GP, Olson WH, Lippman JS, et al. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. Obstet Gynecol. 1997;89(4):615–622. DOI:10.1016/S0029-7844(97)00059-8
   PubMed Web of Science ®Google Scholar
• Lucky AW, Henderson TA, Olson WH, et al. Swinyer LJ. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol. 1997 [cited 2016 Sep 1];37(5):746–754. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9366821
   PubMed Web of Science ®Google Scholar
• Burkman R, Schlesselman JJ, Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol. 2004;190(4 Suppl):S5–22. DOI:10.1016/j.ajog.2004.01.061
   PubMed Web of Science ®Google Scholar
• Maguire K, Westhoff C. The state of hormonal contraception today: established and emerging noncontraceptive health benefits. Am J Obstet Gynecol. 2011;205(4 Suppl):S4–8. DOI:10.1016/j.ajog.2011.06.056
   PubMed Web of Science ®Google Scholar
• Weiss NS, Sayvetz TA. Incidence of endometrial cancer in relation to the use of oral contraceptives. N Engl J Med. 1980;302(10):551–554. DOI:10.1056/NEJM198003063021004
   PubMed Web of Science ®Google Scholar
• Shaw JC. Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients. J Am Acad Dermatol. 2000;43(3):498–502. DOI:10.1067/mjd.2000.105557
   PubMed Web of Science ®Google Scholar
• Kim GK, Del Rosso JQ. Oral spironolactone in post-teenage female patients with acne vulgaris: practical considerations for the clinician based on current data and clinical experience. J Clin Aesthet Dermatol. 2012 [cited 2016 Dec 22];5(3):37–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22468178
   PubMedGoogle Scholar
• Harborne L, Fleming R, Lyall H, et al. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88(9):4116–4123. DOI:10.1210/jc.2003-030424
   PubMed Web of Science ®Google Scholar
• Ash C, Harrison A, Drew S, et al. A randomized controlled study for the treatment of acne vulgaris using high-intensity 414 nm solid state diode arrays. J Cosmet Laser Ther. 2015;17(4):170–176. DOI:10.3109/14764172.2015.1007064
   PubMed Web of Science ®Google Scholar
• Gold MH, Biron JA, Sensing W. Clinical and usability study to determine the safety and efficacy of the Silk’n Blue Device for the treatment of mild to moderate inflammatory acne vulgaris. J Cosmet Laser Ther. 2014;16(3):108–113. DOI:10.3109/14764172.2013.854638
   PubMed Web of Science ®Google Scholar
• Dréno B, Fischer T, Perosino E, et al. Expert opinion: efficacy of superficial chemical peels in active acne management - what can we learn from the literature today? Evidence-based recommendations. J Eur Acad Dermatology Venereol. 2011;25(6):695–704. DOI:10.1111/j.1468-3083.2010.03852.x
   PubMed Web of Science ®Google Scholar
• Firooz A, Tehranchi-Nia Z, Ahmed AR. Benefits and risks of intralesional corticosteroid injection in the treatment of dermatological diseases. Clin Exp Dermatol. 1995;20(5):363–370. DOI:10.1111/j.1365-2230.1995.tb01351.x
   PubMed Web of Science ®Google Scholar
• Thiboutot DM, Weiss J, Bucko A, et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol. 2007;57(5):791–799. DOI:10.1016/j.jaad.2007.06.006
   PubMed Web of Science ®Google Scholar
• Del Rosso JQ, Brandt S. The role of skin care as an integral component in the management of acne vulgaris: part 2: tolerability and performance of a designated skin care regimen using a foam wash and moisturizer SPF 30 in patients with acne vulgaris undergoing active treatment. J Clin Aesthet Dermatol. 2013;6(12):28–36. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L370484961
   PubMedGoogle Scholar
• Shah SK, Alexis AF. Acne in skin of color: practical approaches to treatment. J Dermatolog Treat. 2010;21(3):206–211. DOI:10.3109/09546630903401496
   PubMed Web of Science ®Google Scholar
• Taylor SC, Cook-Bolden F, Rahman Z, et al. Acne vulgaris in skin of color. J Am Acad Dermatol. 2002;46(2):S98–S106. DOI:10.1067/mjd.2002.120791
   Google Scholar
• Callender VD. Acne in ethnic skin: special considerations for therapy. Dermatol Ther. 2004;17(2):184–195. DOI:10.1111/j.1396-0296.2004.04019.x
   PubMedGoogle Scholar
• Alexis AF. Acne vulgaris in skin of color: understanding nuances and optimizing treatment outcomes. J Drugs Dermatol. 2014;13(6):s61.
   PubMed Web of Science ®Google Scholar
• Taylor SC. Utilizing combination therapy for ethnic skin. Cutis. 2007 [cited 2016 Aug 30];80(1 Suppl):15–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17824582
   PubMed Web of Science ®Google Scholar
• Fernandez-Obregon A, Davis MW. The BEST study: evaluating efficacy by selected demographic subsets. Cutis. 2003 [cited 2016 Aug 30];71(2 Suppl):18–26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12630671
   PubMed Web of Science ®Google Scholar
• Alexis AF, Burgess C, Callender VD, et al. The efficacy and safety of topical dapsone gel, 5% for the treatment of acne vulgaris in adult females with skin of color. J Drugs Dermatol. 2016 [cited 2016 Aug 30];15(2):197–204. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26885788
   PubMed Web of Science ®Google Scholar
• Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010 [cited 2016 Dec 22];3(7):20–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20725554
   PubMedGoogle Scholar
• Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg. 1999[cited 2016 Aug 30];25(1):18–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9935087.
   PubMed Web of Science ®Google Scholar
• Alster TS, Tanzi EL, Lazarus M. The use of fractional laser photothermolysis for the treatment of atrophic scars. Dermatol Surg. 2007;33(3):295–299. DOI:10.1111/j.1524-4725.2007.33059.x
   PubMed Web of Science ®Google Scholar
• Lee H, Lee J, Ahn G, et al. Fractional photothermolysis for the treatment of acne scars: a report of 27 Korean patients. J Dermatolog Treat. 2008;19:45–49.
   PubMed Web of Science ®Google Scholar
• Hasegawa T, Matsukura T, Mizuno Y, et al. Clinical trial of a laser device called fractional photothermolysis system for acne scars. J Dermatol. 2006;33(9):623–627. DOI:10.1111/j.1346-8138.2006.00143.x
   PubMed Web of Science ®Google Scholar
• Jacob CI, Dover JS, Kaminer MS. Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol. 2001;45(1):109–117. DOI:10.1067/mjd.2001.113451
   PubMed Web of Science ®Google Scholar
• Chien AL, Qi J, Rainer B, et al. Treatment of acne in pregnancy. J Am Board Fam Med. 2016;29(2):254–262. DOI:10.3122/jabfm.2016.02.150165
   PubMed Web of Science ®Google Scholar
• Bérard A, Azoulay L, Koren G, et al. Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br J Clin Pharmacol. 2007;63(2):196–205. DOI:10.1111/j.1365-2125.2006.02837.x
   PubMed Web of Science ®Google Scholar
• Romøren M, Lindbæk M, Nordeng H. Pregnancy outcome after gestational exposure to erythromycin - a population-based register study from Norway. Br J Clin Pharmacol. 2012;74(6):1053–1062. DOI:10.1111/j.1365-2125.2012.04286.x
   PubMed Web of Science ®Google Scholar
• Rennick GJ. Use of systemic glucocorticosteroids in pregnancy: be alert but not alarmed. Australas J Dermatol. 2006;47(1):34–36. DOI:10.1111/j.1440-0960.2006.00219.x
   PubMed Web of Science ®Google Scholar
• Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62(6):385–392. DOI:10.1002/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z
   PubMedGoogle Scholar
• Murase JE, Heller MM, Butler DC. Safety of dermatologic medications in pregnancy and lactation: part I. pregnancy. J Am Acad Dermatol. 2014;70(3):401.e1-401.e14. DOI:10.1016/j.jaad.2013.09.010
   Web of Science ®Google Scholar
• Del Rosso JQ, Kircik L, Gallagher CJ. Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris. J Clin Aesthet Dermatol. 2015;8(1):31–37.
   PubMedGoogle Scholar
• Gollnick HPM, Graupe K, Zaumseil R-P. 15 % Azelainsauregel in der Behandlung der Akne. Zwei doppelblinde klinische Vergleichsstudien. Azelaic acid 15 % gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies. J Dtsch Dermatol Ges. 2004 [cited 2016 Aug 30];2(10):841–847. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16281587
   PubMedGoogle Scholar